Report Highlights
The global market for antiaging products and services is estimated to increase from $74.8 billion in 2022 to reach $93.2 million by 2027, at a compound annual growth rate (CAGR) of 4.5% from 2022 through 2027.
Report Includes
- 24 data tables and 18 additional tables
- An overview of the global market for antiaging products and services
- Estimation of the market size and analyses of market trends, with data from 2019-2022 and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for antiaging products and services market by product type, and region
- Assessment of the market dynamics and key technological developments of the industry, as well as identification of market trends, opportunities, and challenges affecting the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players, including Beiersdorf AG, Estée Lauder Companies Inc., Koninklijke Philips N.V., L’Oréal SA, Procter & Gamble and Unilever plc
Report Scope
This research report presents an in-depth analysis of the global anti-aging products and services market by product type and geographic region. This report is focused on the aging population, which is the largest user of anti-aging products and services. The report covers products and services specifically affecting the aging demographic.
The report also features an in-depth analysis of key companies operating in the global market for anti-aging products and services. In this report, the market is primarily segmented into two major categories: products and procedures. The products are further segregated into anti-wrinkle products, moisturizers, and sun care products. The procedures segment is categorized into invasive and non-or minimally invasive procedures. Non-invasive procedures are further segmented into dermal fillers, botulinum toxin treatments, laser skin resurfacing, chemical peels, radio frequency (RF) therapy, intense pulsed light (IPL) therapy, microdermabrasion, and other procedures.
The report does not consider drug treatments and hair care products.
The base year of the report is 2021, with historical data provided for 2020 and 2019 and forecast data provided through 2027. Historical, base year and forecast data are provided for each market segment of the report. In terms of geographic region, the report analyzes the global market across North America, Europe, Asia-Pacific and the Rest of the World (RoW).
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||
| Base year market size | $71.6 million | ||||||||||||
| Market size forecast | $93.2 million | ||||||||||||
| Growth rate | CAGR of 4.5% for the forecast period of 2022-2027 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | type and region | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
||||||||||||
Frequently Asked Questions (FAQs)
- L’Oréal
- Unilever
- Estee Lauder
- Beiersdorf
- The Procter & Gamble (P&G) Company
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The total market for anti-aging products and services is valued at $281.6 billion for 2015 and expected to increase to $331.3 billion by the end of 2020, registering a compound annual growth rate (CAGR) of 3.3%.
Report Includes
- An overview of the global markets for antiaging products and services, including definitions and measurements for the baby boomer population
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
- Discussion of individual antiaging markets, products and services, anti-aging applications, technologies, and regions in the context of baby boomer demographics.
- Examination of the market structure and competitive landscape
- A look at market opportunities, categorized into health maintenance, disease treatment, beauty, and personal appearance
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
- Profiles of major players in the industry
Report Highlights
The total market for antiaging products and services was valued at $249.3 billion in 2012. This is expected to increase to nearly $261.9 billion by the end of 2013 and $345.8 billion in 2018, a compound annual growth rate (CAGR) of 5.7% between 2013 and 2018.
Report Includes
- An overview of the global market for antiaging products and services, including definitions and measurements for the baby boomer population.
- Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion of individual antiaging markets, products and services, anti-aging applications, technologies, and regions in the context of baby boomer demographics.
- Examination of the market structure and competitive landscape.
Report Highlights
- The global anti-aging market for the boomer generation was worth $162.2 billion in 2008. This should reach $274.5 billion in 2013, for compound annual growth rate (CAGR) of 11.1%.
- The disease segment generated $66.0 billion in 2008. This is expected to grow at a CAGR of 12.5% to reach $119.2 billion in 2013.
- The appearance segment generated $64.4 billion in 2008. This segment should increase to $105.4 billion in 2013, for a CAGR of 10.4%.
Related Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.
Global Markets and Technologies for Medical Lasers
The global market for medical lasers is estimated to increase from $1.6 billion in 2023 to reach $3.3 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More